Carcinoma, Hepatocellular  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT02069041: A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

Completed
1b
8
RoW
Ramucirumab, IMC-1121B, LY3009806, FOLFOX4, FOLFOX4 (leucovorin + fluorouracil + oxaliplatin)
Eli Lilly and Company
Carcinoma, Hepatocellular
09/16
09/16
NCT00861783: Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma

Completed
1
16
US
irinotecan and ON 01910.Na, camptothecin-11, irinotecan HCl, Camptosar, CPT-11, diaminocyclohexane oxalatoplatinum, rigosertib sodium, oxaliplatin and ON 01910.Na, Eloxatin, oxaloplatinum, oxalatoplatin
Onconova Therapeutics, Inc.
Hepatoma, Advanced Solid Tumor
07/11
07/11
NCT01183663: Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Checkmark Lenalidomide in combination with temsirolimus in pts with adv cancer
Aug 2013 - Aug 2013: Lenalidomide in combination with temsirolimus in pts with adv cancer
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Checkmark Data-AACR
More
Completed
1
180
US
Lenalidomide, CC-5013, Revlimid, Bevacizumab, Avastin, Anti-VEGF monoclonal antibody, rhuMAB-VEGF, Sorafenib, Nexavar, BAY 43-90006, Temsirolimus, CC-779, Torisel, Oxaliplatin, Eloxatin, Leucovorin, Citrovorum, Wellcovorin, 5-fluorouracil, 5-FU, Adrucil, Efudex
M.D. Anderson Cancer Center, Celgene
Advanced Cancers
05/16
05/16

Download Options